TolerogenixX

Heidelberg, Germany

TolerogenixX GmbH has developed a patented and clinically

$7.6M raised

Jul 2023

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has TolerogenixX raised?

TolerogenixX has raised $7.6M in total funding. The most recent round was Series A. The last funding was announced in July 2023.

Who are TolerogenixX's investors?

TolerogenixX's investors include HTGF (High-Tech Gruenderfonds), Kalodion GmbH, CVentures, Biotech Mountains, NISUS.

Where is TolerogenixX headquartered?

TolerogenixX is headquartered in Heidelberg, Germany.

What does TolerogenixX do?

TolerogenixX GmbH has developed a patented and clinically

What stage is TolerogenixX at?

TolerogenixX is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 6, 2023.

MLA

"TolerogenixX — Funding & Investors." VCBacked, July 6, 2023, https://www.vcbacked.co/company/tolerogenixx. Accessed July 2, 2026.

APA

VCBacked. (2023). TolerogenixX — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/tolerogenixx

Wikipedia (cite web)

{{cite web |title=TolerogenixX — Funding & Investors |url=https://www.vcbacked.co/company/tolerogenixx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 6, 2023.